Cargando…
Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
BACKGROUND: About half of Americans 50 to 75 years old do not follow recommended colorectal cancer (CRC) screening guidelines, leaving 40 million individuals unscreened. A simple blood test would increase screening compliance, promoting early detection and better patient outcomes. The objective of t...
Autores principales: | Warren, Jorja D, Xiong, Wei, Bunker, Ashley M, Vaughn, Cecily P, Furtado, Larissa V, Roberts, William L, Fang, John C, Samowitz, Wade S, Heichman, Karen A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271041/ https://www.ncbi.nlm.nih.gov/pubmed/22168215 http://dx.doi.org/10.1186/1741-7015-9-133 |
Ejemplares similares
-
Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay
por: Grützmann, Robert, et al.
Publicado: (2008) -
Diagnostic Value of Methylated Septin9 for Colorectal Cancer Detection
por: Xie, Li, et al.
Publicado: (2018) -
CpG Island Methylation in Colorectal Cancer: Past, Present and Future
por: Curtin, Karen, et al.
Publicado: (2011) -
Clinical value of preoperative methylated septin 9 in Chinese colorectal cancer patients
por: Yang, Xue, et al.
Publicado: (2019) -
Diagnostic Value of Methylated Septin9 for Colorectal Cancer Screening: A Meta-Analysis
por: Yan, Shirong, et al.
Publicado: (2016)